Hypertonic Saline vs. Mannitol in Management of Elevated Intracranial Pressure in Children: A Meta-Analysis

Nihar Ranjan Mishra1, Amit Agrawal2, Rashmi Ranjan Das3

  • 1Department of Pediatrics, All India Institute of Medical Sciences, Kalyani, West Bengal, India.

Insights

Hypertonic saline and mannitol show no significant difference in reducing elevated intracranial pressure (ICP) in children. Evidence for mortality is low certainty, necessitating further high-quality trials.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neuroscience
  • Pharmacology

Background:

  • Elevated intracranial pressure (ICP) is a critical condition in children, often managed with hyperosmolar agents.
  • Hypertonic saline and mannitol are commonly used, but their comparative efficacy and safety in pediatric populations require clear evidence.

Approach:

  • A meta-analysis of four randomized controlled trials (RCTs) involving 365 pediatric patients was conducted.
  • The GRADE system assessed the certainty of evidence for primary (mortality) and secondary outcomes.
  • Searches were performed across relevant databases up to May 31, 2022.

Key Points:

  • No significant difference in mortality rates was observed between hypertonic saline and mannitol groups (RR 1.09, 95% CI 0.74-1.6).
  • Serum osmolality was significantly higher with mannitol. Adverse events included higher rates of shock and dehydration with mannitol, and hypernatremia with hypertonic saline.
  • Certainty of evidence for mortality was low; for secondary outcomes, it ranged from very-low to moderate.

Conclusions:

  • Hypertonic saline and mannitol appear comparable for reducing elevated ICP in children, with no significant impact on mortality.
  • Current evidence is limited, highlighting the need for high-quality RCTs to guide clinical recommendations.
  • Further research is essential to definitively establish optimal treatment strategies and safety profiles.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...